JOSHUA THOMAS: Open Payments
NPI 1336873249 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 36 payments from 12 companies in 2025. Trend: 2023 $1,390 · 2024 $892 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $145 |
| Astellas Pharma US Inc | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| ABBVIE INC. | 3 | $57 |
| Lilly USA, LLC | 3 | $46 |
| Abbott Laboratories | 2 | $38 |
| Eisai Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: OTEZLA, Veozah, QULIPTA, AIRSUPRA, FREESTYLE LIBRE 3, KISUNLA, REPATHA, Leqembi.
Industry payments across AZ — which companies pay providers there.
